USL board said its second forensic audit by EY has revealed fund diversion worth Rs 1,225 cr to Mallya companies.
'It is surprising and unfortunate that unfounded allegations are now being made without any reference to me whatsoever,' Vijay Mallya said.
In 2007, Essar had said it would set up a $1.8-bn unit in Minnesota, but scaled down from a full-scale taconite steel mill project to pellet plant after the 2008 financial crisis
Firm makes disclosures of improper transactions worth Rs 1,225.3 crore with entities linked to beleaguered businessman
There was buzz of Piyush Goyal being elevated to Cabinet rank but only Prakash Javadekar made the cut.
The company had received a loan restructuring package from banks under the 5/25 scheme last year.
Firms to find alternative export routes or face increased trade barriers
JLR, Tata Steel Europe CEOs caution staff on high risks of leaving the EU
India's captains of industry said they were disappointed at the exit of Reserve Bank of India Governor Raghuram Rajan.
The regulator had issued alerts in June and July of 2015.
The FT report said the existence, size and investments of the highly profitable internal trading fund, which was set up three decades ago, have until now remained largely unknown outside a circle of former and current insiders.
Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.
The withdrawal of offer letters is an indication that the company might have overestimated its future business after giving offer letters.
Rajan has a great track record abroad.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.
The good news for the group has come from the port business.
The draft bill allows euthanasia for patients who can take informed decisions; doctors to be protected from liability.
The study claims that from its peak of 18 per cent of gross domestic product in 2008, the crony capitalists' wealth is now down to three per cent
Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances